Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Janssen Research & Development, Shanghai City, China

1 abstract

Abstract
Tumor agnostic efficacy and safety of erdafitinib (erda) in patients (pts) with advanced solid tumors with prespecified FGFR alterations (FGFRalt): RAGNAR primary analysis.
Org: Janssen Research & Development, Beerse, PA, Belgium, Janssen Research & Development, Shanghai City, China, Janssen Research & Development, Spring House, PA,